Bruno Lina, director of the national flu virus monitoring centre for southern France, said that mutations in virus was expected but it doesn’t affect the treatment and vaccines. India’s swine flu toll touches 537, over 16000 affected …
Excerpt from:
H1N1 'not as contagious as other viruses'
Bruno Lina, director of the national flu virus monitoring centre for southern France, said that mutations in virus was expected but it doesn’t affect the treatment and vaccines. India’s swine flu toll touches 485 …
Excerpt from:
Clues found why H1N1 virus kills
Two deaths in France from mutated H1N1 . … skip to main | skip to sidebar. Swine Flu, Symptoms, Treatment , H1N1 , History, Cases, Deaths, Updates … Treatment · Recent Cases by Country · Swine Flu Map Swine Flu Cases in U.S States …
Originally posted here:
Two deaths in France from mutated H1N1
Bruno Lina, director of the national flu virus monitoring centre for southern France, said that mutations in virus was expected but it doesn’t affect the treatment and vaccines. “It was expected, it was announced, and it will happen …
Excerpt from:
Vaccines effective against H1N1 virus mutation, say experts
PARIS – SWINE flu vaccines are still effective despite reported cases of mutations in the A(H1N1) virus, health experts in Europe and North America said Saturday. Bruno Lina, director of the national flu virus monitoring centre for southern France, said the mutation of the virus – blamed for around 6,750 deaths so far worldwide – came as no surprise. ‘It was expected, it was announced, and it …
Continued here:
H1N1 vaccine effective: Experts (Straits Times)
TORONTO – Can cheap and readily available treatments like steroids and cholesterol-lowering statin drugs help save the sickest of H1N1 patients? New efforts by researchers in Canada, the United States and France could help answer this pressing question.
Originally posted here:
Can cheap drugs help save H1N1 patients? Studies aim to find out (The Canadian Press via Yahoo! Canada News)
LYON, France and SWIFTWATER, Pa., Oct. 1 /PRNewswire/ — Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today an interim analysis of data from clinical trials of the U.S.
See more here:
Sanofi Pasteur Announces Results of U.S. Clinical Trials in Adults Following One Dose of Influenza A (H1N1) Vaccine (redOrbit)
The recent news that a single dose of H1N1 (swine flu) vaccine can protect adults against the virus has sparked conversations between the WHO and developed countries about sharing their vaccine stockpiles with developing countries, Bloomberg reports. Because some countries, including Australia, Belgium, Finland, France, Sweden, the U.K. and the U.S.
See original here:
WHO In Talks With Developed Countries About Sharing H1N1 Vaccine With Developing Nations (Medical News Today)